1-8 of 8
Matti Aapro
Close
Sort by
Journal Articles

Cardiac Safety of NEPA, a Fixed-Dose Antiemetic Combination, Administered Prior to Anthracycline-Based Chemotherapy

Meinolf Karthaus, MD, Matti Aapro, MD, Giada Rizzi, M.Sc., Marco Palmas, MD
Journal: Blood
Blood (2014) 124 (21): 4821.
https://doi.org/10.1182/blood.V124.21.4821.4821
Published: 2014
Journal Articles

No Evidence Of Increased Cyclophosphamide Toxicity Associated With The Antiemetic Agent NEPA, a Fixed-Dose Combination Of Netupitant and Palonosetron

Lee Schwartzberg, MD, FACP, Cristina Oprean, MD, Servando Cardona-Huerta, MD, Giada Rizzi, M.Sc., Giorgia Rossi, MD, Marco Palmas, MD, Meinolf Karthaus, MD, Matti Aapro, MD
Journal: Blood
Blood (2013) 122 (21): 2949.
https://doi.org/10.1182/blood.V122.21.2949.2949
Published: 2013
Journal Articles

Current Practice In Diagnosis and Treatment of Chemotherapy-Induced Anemia In Five European Countries – A Patient Record Study

Yves Beguin, MD, PhD, Matti Aapro, MD, Carsten Bokemeyer, MD, John Glaspy, MD, Michael Hedenus, MD, Timothy James Littlewood, MD, FRCP, Heinz Ludwig, MD, Anders Österborg, MD, Daniell Mitchell, PhD
Journal: Blood
Blood (2010) 116 (21): 1512.
https://doi.org/10.1182/blood.V116.21.1512.1512
Published: 2010
Journal Articles

Management of Anemia in Lymphoma Patients Treated with Erythropoiesis Stimulating Agents (ESAs): Findings from the European Anemia Cancer Treatment (A.C.T.) Study

Heinz Ludwig, Carsten Bokemeyer, Pierre Soubeyran, Matti Aapro, Michael Muenzberg, Matthew Turner, Karen MacDonald, Tara Albrecht, Ivo Abraham
Journal: Blood
Blood (2008) 112 (11): 4706.
https://doi.org/10.1182/blood.V112.11.4706.4706
Published: 2008
Journal Articles

Management of Anemia in Patients with Hematological Malignancies Treated with Erythropoiesis Stimulating Agents (ESAs): Findings from the European Anemia Cancer Treatment (A.C.T.) Study

Heinz Ludwig, Pierre Soubeyran, Matti Aapro, Carsten Bokemeyer, Michael Muenzberg, Matthew Turner, Karen MacDonald, Tara Albrecht, Ivo Abraham
Journal: Blood
Blood (2008) 112 (11): 4672.
https://doi.org/10.1182/blood.V112.11.4672.4672
Published: 2008
Journal Articles

Comparison of the Management of Anemia in Patients with Solid Versus Hematological Malignancies Treated with Erythropoiesis Stimulating Agents (ESAs): Findings from the European Anemia Cancer Treatment (A.C.T.) Study

Heinz Ludwig, Matti Aapro, Carsten Bokemeyer, Pierre Soubeyran, Michael Muenzberg, Matthew Turner, Karen MacDonald, Tara Albrecht, Ivo Abraham
Journal: Blood
Blood (2008) 112 (11): 4715.
https://doi.org/10.1182/blood.V112.11.4715.4715
Published: 2008
Journal Articles

Management of Anemia in Multiple Myeloma Patients Treated with Erythropoiesis Stimulating Agents (ESAs): Findings from the European Anemia Cancer Treatment (A.C.T.) Study

Heinz Ludwig, Matti Aapro, Carsten Bokemeyer, Pierre Soubeyran, Michael Muenzberg, Matthew Turner, Karen MacDonald, Tara Albrecht, Ivo Abraham
Journal: Blood
Blood (2008) 112 (11): 4716.
https://doi.org/10.1182/blood.V112.11.4716.4716
Published: 2008
Journal Articles

Pegfilgrastim Provides Effective Primary Prophylaxis Against Febrile Neutropenia in Patients with NHL Undergoing Chemotherapy: Initial Results from an Integrated Analysis - The Neulasta Versus Current Neutropenia Management Practice (Neucup) Project.

Ruth Pettengell, Tomas Skacel, Matti Aapro, Ulrich Duehrsen, Valerie Easton, Gary Lyman
Journal: Blood
Blood (2006) 108 (11): 1150.
https://doi.org/10.1182/blood.V108.11.1150.1150
Published: 2006